Fnevs were tested to promote the activity of the SOD enzyme in colon cancer cells (Figure 2g) and enhance the ability of colon cancer cells to fight free radicals and protect cancer cells from oxidative damage, thus enhancing the activity of colon cancer cells. The gene discussed is SOD1; the disease is malignant colon neoplasm.